Development of the reproductive organs can be strongly affected by the hormonal environment. In the mouse, exposure to estrogens and androgens during the critical developmental period induces estrogen-independent cell proliferation and differentiation in the adult vaginal epithelium, which often results in cancerous lesions later in life. In the present study, we assessed the contributions of estrogen receptor 1 (alpha) (ESR1) to the developmental effects of the nonaromatizable androgen 5alpha-dihydrotestosterone (DHT) on female mouse vagina and external genitalia. The vagina of Esr1 À/À mice treated neonatally with DHT showed atrophic epithelium, whereas the vaginal epithelium of Esr1 +/+ mice was stratified and keratinized even after ovariectomy. In addition, neonatal treatment with DHT led to persistent phosphorylation of ESR1 in the vaginae of 60-dayold ovariectomized mice. We infer from these data that ESR1 is obligatory for the induction and maintenance of persistent vaginal epithelial changes induced by neonatal administration of DHT. Neonatal DHT treatment also induced hypospadias in both Esr1 À/À and Esr1 +/+ mice. In contrast, DHT-induced formation of an os penis-like large bone in the clitoris was found in Esr1
INTRODUCTION
Sex hormones exert developmental effects on humans, laboratory animals, and wildlife. The synthetic estrogen diethylstilbestrol (DES) was routinely prescribed to pregnant women for the prevention of miscarriages from the 1940s to 1970s. In the early1970s, DES was found to induce vaginal clear-cell adenocarcinoma and various malformations in the uterus and vagina of young women exposed in utero [1] . It has been hypothesized that in utero DES exposure increases the subsequent incidence of breast cancer, squamous neoplasia of the cervix and vagina, and vaginal clear-cell adenocarcinoma [2] [3] [4] . As in humans, female mice exposed to natural or synthetic estrogens during the critical period develop estrogen-independent persistent cell proliferation and differentiation of the vaginal epithelium, accompanied by hypospadias [5] [6] [7] [8] . This rodent model has been used to explore the mechanisms underlying reproductive abnormalities induced by developmental DES exposure in humans. However, the molecular mechanism of estrogen-independent vaginal changes induced by perinatal estrogen exposure remains poorly understood.
The developmental actions of estrogens can be mediated through estrogen receptor (ESR)-dependent pathways and/or ESR-independent pathways. These include the induction of DNA adducts, microsatellite instability, sequential mutation, and single-strand breaks seen in both in vitro and in vivo systems [9] . Because ESR 1 (a) (Esr1)-deficient mice do not exhibit stimulatory changes in the reproductive tracts by neonatal DES exposure, developmental effects of estrogens on female reproductive tracts are dependent on ESR1.
Intriguingly, androgens such as testosterone and 5a-dihydrotestosterone (DHT) also induce irreversible changes in female reproductive tracts and external genitalia [10, 11] . It remains controversial whether the effects of androgens on the developing female reproductive organs are mediated through ESR, androgen receptor (AR), or other epigenetic effects. In this study, we investigated the effects of DHT on the developing female reproductive organs in the mouse, particularly the vagina and external genitalia. We found that ESR1 has a critical role in mediating the effects of neonatal DHT exposure in the mouse vagina. We also found that neonatal DHT exposure induced os penis-like large bones in the clitoris in Esr1 À/À mice but not Esr1 þ/þ and Esr1 þ/À mice. Fetal to neonatal stages showing active morphogenesis and development are more sensitive to sex steroids than are adults. Although perinatal sex hormone exposure results in various adverse changes, we understand little about the signaling events induced by treatment with various hormones during the perinatal period. The present results provide the first evidence to date that androgens can induce developmental effects on reproductive organs mediated through ESR1.
MATERIALS AND METHODS

Animals and Treatments
Female C57BL/6J (CLEA, Tokyo, Japan) and Esr1 knockout (KO) mice (C57BL/6J background [12] ) were maintained under 12L:12D at 23-258C and fed laboratory chow (CA-1; CLEA) and tap water ad libitum. All procedures and protocols were approved by the institutional animal care and use committee at the National Institute for Basic Biology.
Female newborn mice were given five daily s.c. injections of 50 lg of DHT (Sigma, St. Louis, MO) per gram of body weight per day dissolved in sesame oil or vehicle alone beginning from Day 0 (the day of birth). Gross morphology of the external genitalia was recorded using a digital camera. Mice were ovariectomized at Day 46 and killed at Day 60. For histological analysis, tissues were fixed in Bouin solution, embedded in paraffin, and sectioned at 8 lm. Sections were stained with hematoxylin-eosin.
Immunohistochemistry
Tissues fixed in 10% formalin neutral buffered solution were embedded in paraffin and sectioned at 4 lm. Deparaffinized sections were incubated in 0.3% H 2 O 2 in methanol for 30 min to eliminate endogenous peroxidases. After washing with PBS, the sections were stained with the DAKO (Carpinteria, CA) LSAB kit according to the manufacturer's supplied protocol. Rabbit polyclonal antibodies against ESR1 and AR were obtained from Novocastra Laboratories (Tyne, England) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively.
For negative controls, normal rabbit immunoglobulin fraction (DAKO) at the same dilution of each antibody was used (data not shown).
Immunoblotting
The samples were prepared as described previously [13] . Protein contents were determined using the Bradford assay (Protein Assay reagent; BioRad, Hercules, CA). Anti-ESR1 was obtained from Santa Cruz Biotechnology, and anti-phospho-ESR1 (Ser 118 and Ser 167 to Ser 122 and Ser 171 of mouse sequences) antibodies were obtained from Cell Signaling Technology (Beverly, MA). The numbering of amino acid residues in this article is according to the human protein sequences, and the manufacturer's product name and specificity of these phosphospecific antibodies against mouse proteins are described in the product information. Signals were detected using the ECL kit (GE Healthcare, Piscataway, NJ).
Transactivation Assays
Full-length mouse ESR1 and AR were constructed by PCR amplification of the entire protein coding region. The PCR product was cut by restriction enzyme, gel purified, and ligated into pcDNA3.1 vector (Invitrogen, Carlsbad, CA). Transactivation assays were carried out as described previously [14, 15] . HEK293 (for ESR1) or HepG2 (for AR) cells were cultured in 24-well plates at 5 3 10 4 cells/well in phenol red-free Dulbecco modified Eagle medium for HEK293 or phenol red-free modified Eagle medium for HepG2 (Sigma) and were supplemented with 10% charcoal/dextran-treated fetal bovine serum 
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(Hyclone, South Logan, UT). After 24 h, the cells were transfected with 400 ng of pGV2-MMTV for AR or pGL3-Basic-4xERE tk-Luc for ESR, 100 ng of pRL-TK (Promega, Madison WI), and 400 ng of pcDNA3.1-ESR1 or pcDNA3.1-AR using Fugene 6 transfection reagent (Roche, Basel, Switzerland) according to the manufacturer's instructions. After 20 h of incubation, steroid hormones (DHT, DES, and 17b-estradiol [E 2 ]; Sigma) were introduced to the media. After an additional 24 h, the cells were collected, and the luciferase activity of the cells was measured by a chemiluminescence assay using the Dual-Luciferase Reporter Assay System (Promega). Promoter activity was calculated as firefly (Photinus pyralis) luciferase activity/sea pansy (Renilla reniformis) luciferase activity. All transfections were performed at least three times using triplicate sample points in each experiment.
RESULTS
AR and ESR1 Expression in Neonatal Mice
The vaginal epithelium in neonatally DHT-treated ovariectomized adult mice (C57BL/6J) was stratified and keratinized as previously reported [11] . Hypospadias with cleft clitoris and a tiny bone in the clitoris were induced in the present study by neonatal DHT exposure as described previously [11] . To examine whether DHT action was mediated through AR or ESR1, we investigated the localizations of AR and ESR1 in female mice at the day of birth.
In general, both receptors were strongly immunostained in vaginae at the day of birth. ESR1 was expressed in the Müllerian duct-derived vaginal epithelial cells and stromal cells (Fig. 1A) and was faintly expressed in cells of the sinus cord and distal vaginal rudiment derived from urogenital sinus (Fig.  1B) . In contrast to ESR1, AR was not detected in Müllerian duct-derived vaginal epithelial cells but was instead expressed in stromal cells (Fig. 1C) . Androgen receptor was detected in urogenital sinus-derived distal vaginal epithelial cells showing solid cord and in the mesenchymal cells (Fig. 1D) .
Vaginal Histology and External Morphology of Esr1 KO Mice Given Neonatal DHT Exposure
Although AR was not expressed in the Müllerian ductderived vaginal epithelial cells, normal vaginal epithelial morphogenesis requires vaginal stromal cells [16] . In addition, stromal components contribute to developmental effects on the uterus and vagina [17] . Thus, we could not rule out a possible role for AR in mediating the DHT-induced persistent vaginal changes. To determine whether ESR was required for DHT action in the neonatal vagina, we utilized Esr1 KO mice. ESR1 was not detected in the Esr1 À/À mice ( Fig. 1, E 
and F). In contrast, AR expression in the Esr1
À/À female reproductive organs was similar to that of Esr1 þ/þ mice (Fig. 1 , G and H), indicating that AR expression is independent of ESR1.
The effects of neonatal DHT exposure on organ weights, vaginal histology, and external genitalia are summarized in Table 1 . The vaginal epithelium of ovariectomized Esr1 þ/þ mice exposed neonatally to DHT (Esr1 þ/þ -DHT) showed ovary-independent proliferation consisting of seven to 12 layers of cells with superficial keratinization (Fig. 2A) . In contrast, atrophic vaginal epithelium was found in ovariectomized 60-day-old Esr1 þ/þ mice exposed neonatally to oil DHT EFFECTS THROUGH ESR1 499 vehicle alone (Fig. 2B) . In four of five ovariectomized Esr1 þ/À mice treated neonatally with DHT (Esr1 þ/À -DHT), the vaginal epithelium was composed of two to four layers of cells. However, keratin and detached epithelial cells were observed in the vaginal lumen (Fig. 2C) , indicating that these Esr1 þ/À -DHT mice showed an ovary-dependent vaginal epithelial phenotype. The elements in its alternating layers indicate multiple ovarian cycles in the Esr1 þ/À -DHT mice. This phenotype was also seen when mice were treated neonatally with a relatively low concentration of estrogen [18] . The remaining Esr1 þ/À -DHT mouse showed ovary-independent vaginal epithelial stratification and superficial keratinization.
The ovariectomized Esr1
À/À mice treated neonatally with DHT (Esr1 À/À -DHT) all had a vaginal epithelium with one to two layers of cells and never showed mucus and keratin in the lumen (Fig. 2D) . Taken together, these results indicated that DHT-induced vaginal epithelial changes were mainly mediated through ESR1. In support of this result, we found using a reporter gene assay that high-dose DHT can indeed stimulate the transcriptional activity of ESR1 (Fig. 3A) . In contrast, transcriptional activity of mouse AR was not induced by DES (Fig. 3B) .
The morphology of external genitalia showed no differences between intact Esr1 þ/þ and Esr1 À/À mice (Fig. 4, A , and Esr1 À/À groups treated neonatally with DHT exhibited hypospadias and formation of a common urethralvaginal canal, accompanied by a wide cleft clitoris independent of their genotypes (Fig. 4, C-F) . Intriguingly, only Esr1
-DHT mice) formed an os penis-like bony structure that extruded from the clitoris ( Table 1 and Fig. 4, E and F) .
Neonatal DHT Exposure Induces Phosphorylation of ESR1 in Mouse Vagina
ESR1 was persistently phosphorylated in the vagina of ovariectomized mice treated neonatally with DES, leading to ovary-independent epithelial cell proliferation and keratinization [13] . We tested whether neonatal DHT exposure induces phosphorylation of ESR1 in later life using anti-phospho-ESR1 antibodies. As shown in Figure 5 , neonatal DHT exposure induced phosphorylation of ESR1 in vaginae from ovariectomized mice. Therefore, ESR1 is obligatory for both induction and maintenance of persistent vaginal epithelial cell proliferation and differentiation caused by neonatal DHT exposure, which is similar to results from neonatal DES exposure [13] .
DISCUSSION
Androgens mediate various aspects of physiological functions not only in males but also in females. However, the physiological and developmental roles of androgen action in immature female reproductive organs have not been clarified. Both ESR1 and AR are expressed in female embryos and neonates [19] [20] [21] . The present study also showed that AR and ESR1 were expressed in the epithelium of female reproductive tracts and their surrounding mesenchyme in neonates. Developing female reproductive organs in neonates are affected by hormones and hormone-like chemicals and can induce various adverse effects [22] . Clarification of the signaling pathway of steroid hormones is thus important for understanding molecular events in reproductive tracts during animal development. In the present study, we analyzed the developmental effects of DHT on the female reproductive organs using Esr1 KO mice.
The normal development and differentiation of reproductive tract components derived from the Mü llerian duct and urogenital sinus are dependent on the hormonal environment during critical periods of morphogenesis. Laboratory and epidemiological findings showed that developmental exposure within the critical period to sex steroids, particularly estrogens, induced various abnormalities in reproductive organs and often led to cancers later in life [23] . In utero DES exposure induces vaginal clear-cell adenocarcinoma in young women [1] , as well as various developmental abnormalities in the reproductive tracts later in life, including squamous neoplasia of the cervix and vagina and vaginal clear-cell adenocarcinoma [3] . To help in understanding the DES syndrome, a laboratory rodent model has been characterized. Mice treated perinatally with DES 
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exhibit estrogen-independent proliferation and keratinization in the vaginal epithelium and develop cancers later in life [11, 18, 24] . ESR1 has an essential role in the induction of estrogenindependent vaginal changes caused by neonatal DES exposure, as such exposure did not result in morphological changes in Esr1 À/À mice [25] . Intriguingly, neonatal treatment with androgens also induced irreversible effects in female reproductive tracts and external genitalia as reviewed previously [26] . Indeed, high concentrations of both testosterone and DHT induced a uterotrophic effect in ovariectomized rats [27] . Because DHT is a nonaromatizable androgen, it would be expected to act primarily through AR. However, a study [28] of Ar KO mice showed that AR is dispensable for uterine function. Thus, it has not been clarified how DHT induces developmental effects in female reproductive organs. To test the necessity of ESR for the developmental effects of DHT, we used Esr1 KO mice. We found that Esr1 þ/þ -DHT mice showed ovary-independent vaginal epithelial cell proliferation, stratification, and keratinization, while Esr1 À/À -DHT mice showed atrophic epithelium with neither stratification nor keratinization. These results indicate that persistent vaginal changes by neonatal DHT treatment are mediated through ESR1.
In support of this idea, we found that high concentrations of DHT can activate the ESR, whereas DES cannot activate the AR. Despite that the relative binding and transcriptional ability of DHT to ESR is 0.001% that of estradiol [29, 30] , DHT action through ESR1 mimics the action of estrogens in the developing vagina. This is potentially of concern because much of the evidence regarding effects of hormonally active agents has dealt with altered sexual development [22] , and most hormonally active agents known to date are more likely to bind to ESR than to AR [31, 32] . Nevertheless, the estrogen-like chemical bisphenol-A, which binds poorly to ESR, induces estrogen-independent vaginal epithelial cell proliferation and keratinization [33] . Recently, additional nongenomic effects of sex steroids have been established. Androgen receptor has been found to interact with the intercellular tyrosine kinase SRC (cSrc) and can function cooperatively with ESR1 and following signal transduction activation [34, 35] . In the present study, we could not exclude the possible involvement of AR in DHTtreated mouse vagina. Further analysis is necessary to determine whether DHT directly binds to and activates ESR1 in vivo.
Neonatal DES exposure induced persistent phosphorylation of ESR1 even in the absence of estrogen ligands, and this phosphorylation maintains the estrogen-independent cell proliferation and differentiation of the vaginal epithelium [13] . Such estrogen-independent ESR1 phosphorylation was also detected in the neonatally DHT-treated vagina. Thus, the effects of neonatal DHT exposure are similar to those resulting from neonatal DES treatment in adult mice. This result shows that ESR1 is essential for not only induction but also DHT EFFECTS THROUGH ESR1 maintenance of persistent vaginal changes caused by neonatal DHT exposure.
The involvement of ESR1 has been reported in disorders of male rat penis induced by estrogen [36, 37] ; however, the developmental effects of female mouse external genitalia elicited by androgens have been unelucidated. Development of external genitalia is dependent on sex steroid hormones during the perinatal stage [38] [39] [40] . The induction of penis-like enlargements and formation of bone tissue in the clitoris (os clitoris) by neonatal administration of androgens has been observed in female mice and rats [11, 41] . Os clitoris formation was not induced by estrogens [11, 41] , establishing it as an androgen-dependent phenomenon. Indeed, os penis formation in male mice is dependent on androgens during the early period [42] . In the present study, the formation of a tiny bone in the clitoris was induced by neonatal DHT exposure in Esr1 þ/þ and Esr1 þ/À mice as in C57BL/Tw mice [10, 11] . Intriguingly, only Esr1 À/À mice treated neonatally with DHT formed a large os clitoris that was similar to the os penis in which three bones are present. It cannot be explained by a high serum testosterone level in the female Esr1 KO mice [43] because oil-treated Esr1 À/À control mice did not show such large os clitoris formation. The difference in response to DHT in these mice may be due to AR expression levels in mesenchymal cells of the clitoris. In support of this idea, AR expression in the bone of Esr1 À/À mice is 2-fold higher than that of normal mice [44] . In contrast to os penis formation, hypospadias and cleft clitoris occurred in all animals that received neonatal DHT exposure. Female hypospadias is characterized by clefting of the clitoris and mislocalization of vaginal and urethral openings. The formation of hypospadias results from an imbalance between cell proliferation and apoptosis in the urogenital sinus in response to sex steroid hormone exposure [7] . Thus, DHT exerts the developmental effects in the urogenital sinus without ESR1 activation.
In summary, ESR1 was indispensable for the induction of persistent vaginal epithelial cell proliferation and differentiation in response to neonatal administration of DHT. Persistent phosphorylation of ESR1 reveals an essential role of ESR1 for the maintenance of developmental effects of the vagina. Neonatal treatment of female mice with sex steroid hormones and estrogenic chemicals induced various morphological and functional changes [26, 33] ; therefore, it is important to clarify the mediator that induces such effects. Studies [25, 45] have shown that the developmental effects in mouse reproductive organs elicited by estrogen are mediated through ESR1, but the present study is the first to date to provide evidence that androgen-induced developmental effects require ESR1 activation. Further analysis is needed to understand the developmental effects of sex steroid hormones and hormonally active agents and the functions of ESR and AR in developing reproductive organs.
